Suchergebnisse - Uwe Hahn

  • Treffer 1 - 9 von 9
Treffer weiter einschränken
  1. 1
    Glucose Transporter Proteins (GLUT) in Human Endometrium: Expression, Regulation, and Function throughout the Menstrual Cycle and in Early Pregnancy

    Glucose Transporter Proteins (GLUT) in Human Endometrium: Expression, Regulation, and Function throughout the Menstrual Cycle and in Early Pregnancy von Michael von Wolff, Stefanie Ursel, Uwe Hahn, R. Steldinger, T. Strowitzki

    Veröffentlicht 2003
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  2. 2
    Pharmacokinetic and Pharmacodynamic Comparison of Enteric-Coated Mycophenolate Sodium and Mycophenolate Mofetil in Maintenance Renal Transplant Patients

    Pharmacokinetic and Pharmacodynamic Comparison of Enteric-Coated Mycophenolate Sodium and Mycophenolate Mofetil in Maintenance Renal Transplant Patients von Klemens Budde, Steffen Bauer, Pia Hambach, Uwe Hahn, H Röblitz, Ingrid Mai, Fritz Diekmann, HH Neumayer, Petra Glander

    Veröffentlicht 2007
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  3. 3
    Two novel JAK2 exon 12 mutations in JAK2V617F-negative polycythaemia vera patients

    Two novel JAK2 exon 12 mutations in JAK2V617F-negative polycythaemia vera patients von C M Butcher, Uwe Hahn, Luen Bik To, Jozef Gécz, Ella Wilkins, Hamish S. Scott, Peter Bardy, Richard J. D’Andrea

    Veröffentlicht 2007
    Volltext
    Carta
    Zu den Favoriten
    Gespeichert in:
  4. 4
    Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation

    Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation von H. Euler, A Marmont, Andrea Bacigalupo, S. Fastenrath, Peter Dreger, M. Hoffknecht, AR Zander, Berthold Schalke, Uwe Hahn, R Haas, N Schmitz

    Veröffentlicht 1996
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  5. 5
    Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trial

    Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trial von Fekade B. Sime, Michael S. Roberts, Ing Soo Tiong, Julia H. Gardner, Sheila Lehman, Sandra Peake, Uwe Hahn, Morgyn S. Warner, Jason A. Roberts

    Veröffentlicht 2015
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  6. 6
    Altered Pharmacokinetics of Piperacillin in Febrile Neutropenic Patients with Hematological Malignancy

    Altered Pharmacokinetics of Piperacillin in Febrile Neutropenic Patients with Hematological Malignancy von Fekade B. Sime, Michael S. Roberts, Morgyn S. Warner, Uwe Hahn, Thomas A. Robertson, Sue Yeend, Andy Phay, Sheila Lehman, Jeffrey Lipman, Sandra Peake, Jason A. Roberts

    Veröffentlicht 2014
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  7. 7
    Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14

    Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients a... von Mark Hertzberg, Maher K. Gandhi, Judith Trotman, Belinda Butcher, John Taper, Amanda Johnston, Devinder Gill, Shir‐Jing Ho, Gavin Cull, Keith Fay, Geoff Chong, Andrew Grigg, Ian D. Lewis, Sam Milliken, William Renwick, Uwe Hahn, Robin Filshie, George Kannourakis, Anne-Marie Watson, Pauline Warburton, Andrew Wirth, John F. Seymour, Michael S. Hofman, Rodney J. Hicks

    Veröffentlicht 2016
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  8. 8
    Sorafenib plus intensive chemotherapy in newly diagnosed <i>FLT3</i>-ITD AML: a randomized, placebo-controlled study by the ALLG

    Sorafenib plus intensive chemotherapy in newly diagnosed <i>FLT3</i>-ITD AML: a randomized, placebo-controlled study by the ALLG von Sun Loo, Andrew W. Roberts, Natasha S. Anstee, Glen Kennedy, Simon He, Anthony P. Schwarer, Anoop K. Enjeti, James D’Rozario, Paula Marlton, Ian Bilmon, John Taper, Gavin Cull, Campbell Tiley, Emma Verner, Uwe Hahn, Devendra Hiwase, Harry Iland, Nick Murphy, Sundra Ramanathan, John Reynolds, Doen Ming Ong, Ing Soo Tiong, Meaghan Wall, Michael T. Murray, Tristan Rawling, Joanna Leadbetter, Leesa Rowley, Maya Latimer, Sam Yuen, Stephen B. Ting, Chun Yew Fong, Kirk Morris, Ashish Bajel, John F. Seymour, Mark J. Levis, Andrew H. Wei

    Veröffentlicht 2023
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  9. 9
    Targeting MCL‐1 and BCL‐2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non‐Hodgkin lymphoma: Results from preclinical models and a Phase Ib study

    Targeting MCL‐1 and BCL‐2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non‐Hodgkin lymphoma: Results from preclinical models and a Phase Ib study... von Elisabeth A. Lasater, Dhara N. Amin, Rajat Bannerji, Raghuveer Singh Mali, Kathy Barrett, Ryan N. Rys, Jason Oeh, Eva Lin, Tim Sterne‐Weiler, Ellen Ingalla, MaryAnn Go, Shang‐Fan Yu, Maxwell M. Krem, Chris Arthur, Uwe Hahn, Anna Johnston, Vinit Karur, Nadia Khan, Paula Marlton, Tycel Phillips, Giuseppe Gritti, John F. Seymour, Monica Tani, Sam Yuen, Scott E. Martin, Matthew T. Chang, Christopher M. Rose, Victoria C. Pham, Andrew G. Polson, YiMeng Chang, Claudia M. Wever, Nathalie A. Johnson, Yanwen Jiang, Jamie Hirata, Deepak Sampath, Lisa Musick, Christopher R. Flowers, Ingrid E. Wertz

    Veröffentlicht 2023
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: